Obesity and Alzheimer's disease share overlapping metabolic disturbances that show up early in the disease process, often well before any clinical symptoms appear. That is the central conclusion of a review from Florida Atlantic University published in the journal Cells, which pulls together evidence on how disruptions in whole-body metabolism ripple into the brain.
The review focuses on the biological traffic between fat tissue, metabolism and the central nervous system. Adipose tissue is not inert storage; it participates in signaling that reaches the brain, and the authors examine the pathways through which these interactions may contribute to neurodegeneration and cognitive decline. Obesity is already established as a major driver of metabolic disease, and the accumulating evidence tying it to brain health puts it in a different category than a purely cardiovascular or diabetes-related concern.
The timing matters as much as the mechanism. The population aged 65 and older in the United States is projected to reach 71 million by 2030, roughly one in five Americans, and Alzheimer's already affects about one in nine adults over 65. Obesity prevalence among older adults has nearly doubled in recent decades, meaning two trends that may reinforce each other are rising together.
Because the metabolic changes the authors describe emerge before cognitive symptoms, they represent a window in which the biology is measurable and potentially modifiable. This is a synthesis of existing research rather than a new experiment, so it maps out where the mechanistic evidence points and what remains to be tested, rather than establishing that treating metabolic dysfunction changes the trajectory of dementia.